• References (275)
  • Citations (87)
Published on Dec 12, 2016
Peter J. Neumann78
Estimated H-index: 78
Theodore G. Ganjats57
Estimated H-index: 57
+ 2 AuthorsJoanna E. Siegel16
Estimated H-index: 16
1. Cost-Effectiveness Analysis as a Guide to Resource Allocation in Health: Roles and Limitations 2. Theoretical Foundations of Cost-Effectiveness Analysis 3. Framing and Designing the Cost-Effectiveness Analysis 4. Identifying and Valuing Outcomes 5. Assessing the Effectiveness of Health Interventions 6. Estimating Costs in Cost-Effectiveness Analysis 7. Time Preference 8. Reflecting Uncertainty in Cost-Effectiveness Analysis 9. Reporting Cost-Effectiveness Studies and Results Appendix A: Summa...
Published on Jan 1, 2008
Gordon H. Guyatt199
Estimated H-index: 199
Drummond Rennie63
Estimated H-index: 63
Medical practice is constantly changing. The rate of change is accelerating, and physicians can be forgiven if they often find it dizzying. How can physicians learn about new information and innovations, and decide how (if at all) they should modify their practice? Possible sources include summaries from the medical literature (review articles, practice guidelines, consensus statements, editorials, and summary articles in "throwaway" journals); consultation with colleagues who have special exper...
Published on Jun 1, 2004in Journal of Bone and Joint Surgery, American Volume4.72
Kevin J. Bozic53
Estimated H-index: 53
Read Pierce6
Estimated H-index: 6
(UCSF: University of California, San Francisco),
James H. Herndon42
Estimated H-index: 42
Health care technology (defined as all drugs, devices, and medical and surgical procedures used in medical care as well as the organizational and supportive systems within which such care is provided) is widely regarded as an important driver of escalating health care spending in the United States. Many new health care technologies are adopted and used in clinical practice with little or no evidence that their use is associated with improved patient outcomes. Orthopaedic surgeons are facing incr...
Published on Sep 24, 2003in JAMA51.27
Sean Tunis35
Estimated H-index: 35
(AHRQ: Agency for Healthcare Research and Quality),
Daniel Stryer12
Estimated H-index: 12
Carolyn M. Clancy37
Estimated H-index: 37
Decision makers in health care are increasingly interested in using highquality scientific evidence to support clinical and health policy choices; however, the quality of available scientific evidence is often found to be inadequate. Reliable evidence is essential to improve health care quality and to support efficient use of limited resources. The widespread gaps in evidencebased knowledge suggest that systematic flaws exist in the production of scientific evidence, in part because there is no ...
Published on Sep 1, 2003in Acc Current Journal Review
T.B. Ferguson1
Estimated H-index: 1
Eric D. Peterson8
Estimated H-index: 8
Laura P. Coombs17
Estimated H-index: 17
IN 1917 ERNEST CODMAN, MD, A Massachusetts surgeon, described his view of a quality evaluation system for medicine, in which clinicians assessed outcomes and the processes that led to those outcomes. The modern iteration of Codman’s quality system for medicine is continuous quality improvement (CQI). Adapted from industrial manufacturing principles in Japan and the United States, CQI in medicine is the repetitive cycle of process and outcomes measurement, design and implementation of interventio...
Published on Jul 2, 2003in JAMA51.27
Sameer Chopra10
Estimated H-index: 10
A thin film formation apparatus for forming a thin film on a substrate is provided, which comprises: a reaction chamber; a gas introduction section for introducing a reactant gas into the reaction chamber; an evacuation section for exhausting the reactant gas from the reaction chamber; first and second planar electrodes provided in the reaction chamber; first and second support members which respectively support the first and second electrodes in parallel relation; a high frequency power source ...
Published on Jun 26, 2003in The New England Journal of Medicine70.67
Elizabeth A. McGlynn51
Estimated H-index: 51
(AN: RAND Corporation),
Steven M. Asch63
Estimated H-index: 63
(UCLA: University of California, Los Angeles)
+ 4 AuthorsEve A. Kerr49
Estimated H-index: 49
background We have little systematic information about the extent to which standard processes involved in health care — a key element of quality — are delivered in the United States. methods We telephoned a random sample of adults living in 12 metropolitan areas in the United States and asked them about selected health care experiences. We also received written consent to copy their medical records for the most recent two-year period and used this information to evaluate performance on 439 indic...
Published on May 29, 2003in The New England Journal of Medicine70.67
Jacob Lalezari44
Estimated H-index: 44
(UCSF: University of California, San Francisco),
Keith Henry49
Estimated H-index: 49
(HCMC: Hennepin County Medical Center)
+ 13 AuthorsJoseph J. Eron82
Estimated H-index: 82
(UNC: University of North Carolina at Chapel Hill)
Background The T-20 vs. Optimized Regimen Only Study 1 (TORO 1) was a randomized, open-label, phase 3 study of enfuvirtide (T-20), a human immunodeficiency virus type 1 (HIV-1) fusion inhibitor. Methods Patients from 48 sites in the United States, Canada, Mexico, and Brazil with at least six months of previous treatment with agents in three classes of antiretroviral drugs, resistance to drugs in these classes, or both, and with at least 5000 copies of HIV-1 RNA per milliliter of plasma were rand...
Published on May 22, 2003in The New England Journal of Medicine70.67
Ramsey Sd1
Estimated H-index: 1
(UCSD: University of California, San Diego),
Berry K1
Estimated H-index: 1
(UCSD: University of California, San Diego)
+ 3 AuthorsDouglas E. Wood39
Estimated H-index: 39
(UW: University of Washington)
background The National Emphysema Treatment Trial, a randomized clinical trial comparing lungvolume–reduction surgery with medical therapy for severe emphysema, included a prospective economic analysis. methods After pulmonary rehabilitation, 1218 patients at 17 medical centers were randomly assigned to lung-volume–reduction surgery or continued medical treatment. Costs for the use of medical care, medications, transportation, and time spent receiving treatment were derived from Medicare claims ...
Cited By87
Lars Bondemark28
Estimated H-index: 28
(Malmö University),
Jenny Kallunki1
Estimated H-index: 1
(Malmö University),
Liselotte Paulsson3
Estimated H-index: 3
(Malmö University)
Abstract Background and aim Class II malocclusion is one of the most common malocclusions in young children and a great deal of research on this topic has been undertaken. Despite this, there are still knowledge gaps on whether it is effective to treat these malocclusions early or what type of treatment should be performed. The aim of this article was to systematically review and update the quality of evidence for various treatment modalities considering Class II malocclusion correction before 1...
Published on Jul 5, 2019in Health technology
Yiannis Nikolaidis7
Estimated H-index: 7
(UoM: University of Macedonia),
George Efthymiadis1
Estimated H-index: 1
(UoM: University of Macedonia),
Pantelis Angelidis8
Estimated H-index: 8
(UoWM: University of Western Macedonia)
The use of technology advancements and telemedicine has definitely contributed to reducing the communication gap between patients and doctors. Lately, a telemedicine program is applied in Greece aiming at the improvement of primary health services offered to Greek citizens, especially of remote and rural areas. The program is supported by the Greek National Health Service, while it is fully funded and run by Vodafone Greece. Vodafone offers doctors of 100 remote areas of continental Greece and G...
Published on Jan 4, 2019in PLOS ONE2.78
Stephen Mac1
Estimated H-index: 1
(U of T: University of Toronto),
Stephen Mac1
Estimated H-index: 1
+ 0 AuthorsBeate Sander17
Estimated H-index: 17
Introduction While Lyme disease (LD) is mostly treatable, misdiagnosed or untreated LD can result in debilitating sequelae and excessive healthcare usage. The objective of this review was to characterize the body of literature on the economic burden of Lyme disease (LD) and the cost-effectiveness of LD interventions, such as antibiotic treatment and vaccination. Methods We followed Joanna Briggs Institute scoping review methodologies. We systematically searched terms related to LD, economic eval...
Published on Jan 1, 2019
Flávio Mauricio Garcia Pezzolla (UFSC: Universidade Federal de Santa Catarina), Priscila Sousa de Avelar1
Estimated H-index: 1
(UFSC: Universidade Federal de Santa Catarina)
+ 1 AuthorsRenato Garcia12
Estimated H-index: 12
(UFSC: Universidade Federal de Santa Catarina)
This paper presents a study to assist of a Decision Support Systems and Clinical Engineering Health Technology Management. The methodology is based on methodological guideline for the evaluation of medical equipment addressing its main domains (Clinical, Admissibility, Technical, Operational and Economic) in order to verify the incorporation of Hyperbaric Chambers in comparison to the outsourcing service for the injuries treatment diabetes carriers in Santa Catarina, Brazil. The HBOT application...
Published on Dec 1, 2018in European Journal of Public Health2.23
Maria Lucia Specchia13
Estimated H-index: 13
(UCSC: Catholic University of the Sacred Heart),
Giuseppe La Torre36
Estimated H-index: 36
+ 5 AuthorsChiara De Waure2
Estimated H-index: 2
(University of Perugia)
Published on May 4, 2018in Journal of Medical Economics
Florian Dams (University of Bern), Javier Leonardo González Rodríguez (Del Rosario University)+ 2 AuthorsMickaël Hiligsmann27
Estimated H-index: 27
(PHRI: Public Health Research Institute)
AbstractObjectives: Several studies, mostly from developed countries, have identified barriers and facilitators with regard to the uptake of health technology assessment (HTA). This study elicited, using best-worst scaling (BWS), what HTA experts in Colombia consider to be the most important barriers and facilitators in the use of HTA, and makes a comparison to results from the Netherlands.Methods: Two object case surveys (one for barriers, one for facilitators) were conducted among 18 experts (...
Published on Jan 1, 2018
Abstract To reach the healthcare market and have a medical intervention reimbursed in any format carries high risk and very low success rates. Even when all regulatory hurdles have been surpassed, there is no guarantee that the product will be purchased; a different body makes that decision using criteria typically unknown to early-stage innovators and intervention developers. In the context of skeletal muscle diseases, the field is at a crossroads; accurate diagnoses are difficult to obtain, pa...
Published on Sep 1, 2017in European Journal of Cancer6.68
A. Sobrero48
Estimated H-index: 48
Alberto Puccini4
Estimated H-index: 4
+ 1 AuthorsPaoloBruzzi63
Estimated H-index: 63
Abstract There are several controversies in the assessment of the benefit, value and sustainability of cancer drugs. First, there is a surprising disagreement on the impact of drugs on the overall outcome of cancer treatment. Second, raising the bar of efficacy in clinical trials is claimed by many, but at the same time, being conservative appears justified as well, given the overall benefit of multiple incremental gains, typically observed in advanced solid tumours. Third, sustainability of can...
Published on Apr 1, 2017
Grace Hampson2
Estimated H-index: 2
Adrian Towse24
Estimated H-index: 24
Chris Henshall13
Estimated H-index: 13
The 2015 meeting of the HTAi Asia Policy Forum meeting was held in Singapore, 29th -30th October 2015. The topic of the meeting was - How can HTA meet the needs of health system and government decision makers? This report represents the background paper for the meeting, as developed by OHE. The report sets out the issues to be addressed in considering where and when HTA could be a useful aid for decision making, what HTA can be used to achieve, and where the evidence for HTA can be obtained from...
View next paperThe development of health technology assessment